Subtle, previously unknown innate immune responses working quietly and efficiently
En un laboratorio controlado, treinta y seis voluntarios sanos fueron expuestos directamente al SARS-CoV-2, y la variación en sus respuestas inmunitarias ha revelado algo que la ciencia buscaba desde el inicio de la pandemia: por qué algunos cuerpos simplemente no dejan que el virus se instale. Investigadores del Wellcome Sanger Institute, el University College London y el Imperial College London han publicado en Nature los hallazgos más detallados hasta la fecha sobre los mecanismos innatos que protegen a ciertas personas, no mediante una respuesta agresiva, sino mediante una vigilancia silenciosa y precisa que actúa antes de que el virus pueda establecerse. Este trabajo, enmarcado en el ambicioso proyecto Human Cell Atlas, nos recuerda que la protección más profunda a veces no hace ruido.
- Algunos cuerpos eliminaron el virus casi sin que el sistema inmunitario pareciera esforzarse, mientras otros, pese a responder rápido en sangre, llegaron tarde al lugar donde realmente importaba: la nariz.
- El gen HLA-DQA2 estaba inusualmente activo en las personas resistentes incluso antes de la exposición, como si su sistema inmunitario llevara tiempo escuchando una amenaza que aún no había llegado.
- Los seis voluntarios que desarrollaron infección sostenida revelaron un patrón inquietante: su tejido nasal respondió con retraso, dando al virus el tiempo justo para afianzarse antes de que llegaran las defensas.
- El equipo secuenció más de 600.000 células individuales, construyendo la línea de tiempo más completa jamás producida sobre cómo el cuerpo humano enfrenta un patógeno nuevo.
- Los patrones identificados en los receptores de células T de los individuos protegidos abren la puerta a terapias dirigidas y vacunas que imiten lo que estos cuerpos ya hacen de forma natural.
Treinta y seis voluntarios sanos permitieron que les rociaran el coronavirus directamente en la nariz. Lo que ocurrió después —y sobre todo, lo que ocurrió de forma distinta en cada uno de ellos— ha proporcionado a la ciencia su imagen más nítida hasta ahora de por qué ciertos organismos simplemente no dejan que el virus prospere.
El equipo, formado por investigadores del Wellcome Sanger Institute, el University College London y el Imperial College London, buscaba trazar con precisión la secuencia de eventos inmunitarios que se desencadenan en los primeros momentos tras la exposición al SARS-CoV-2. No todos los participantes enfermaron, y esa variación se convirtió en la clave del estudio. Los hallazgos, publicados en Nature, forman parte del Human Cell Atlas, un proyecto internacional que aspira a catalogar cada tipo de célula del cuerpo humano para transformar nuestra comprensión de la salud y la enfermedad.
Los investigadores analizaron muestras de sangre y tejido nasal en tiempo real, secuenciando más de 600.000 células individuales. Lo que encontraron desafió la intuición médica habitual: las personas que eliminaron el virus rápidamente no desarrollaron una respuesta inmunitaria amplia y agresiva, sino reacciones innatas sutiles y desconocidas hasta ahora, actuando en silencio antes de que el sistema adaptativo entrara en juego. Un dato destacó especialmente: los individuos resistentes mostraban alta actividad del gen HLA-DQA2 incluso antes de la exposición, como si su sistema inmunitario ya estuviera en alerta.
Los seis voluntarios que desarrollaron infección sostenida contaron una historia diferente: su sangre respondió con rapidez, pero el tejido nasal —el verdadero frente de batalla— reaccionó con retraso. Para cuando llegaron las defensas, el virus ya se había instalado. Los investigadores también identificaron patrones comunes en la activación de receptores de células T en los individuos protegidos, lo que sugiere nuevas vías para desarrollar terapias dirigidas y vacunas que repliquen estos mecanismos naturales de protección.
La investigadora principal Sarah Teichmann, cofundadora del Human Cell Atlas, subrayó que a medida que este mapa celular se complete, será posible identificar qué células son verdaderamente esenciales para combatir infecciones y entender por qué personas distintas responden de manera tan diferente al mismo virus. El trabajo apunta hacia una medicina capaz de enseñarle al sistema inmunitario lo que ciertos cuerpos ya saben hacer por sí solos.
Thirty-six healthy volunteers walked into a laboratory and had the coronavirus sprayed directly into their noses. What happened next—or rather, what happened differently in each of them—has given scientists their clearest picture yet of why some people's bodies simply refuse to let the virus take hold.
The research team, drawn from the Wellcome Trust Sanger Institute, University College London, and Imperial College London, was hunting for something that had never been clearly mapped before: the precise sequence of immune events that unfolds in the first moments after exposure to SARS-CoV-2. Not everyone in the study got sick. That variation—the fact that some bodies mounted a successful defense while others did not—became the key to understanding what protection actually looks like at the cellular level. The findings, published in Nature this week, represent part of a larger international effort called the Human Cell Atlas, an ambitious project to catalog every type of cell in the human body and use that knowledge to reshape how we understand health and disease.
The researchers tracked blood samples and nasal tissue from their volunteers with meticulous care, watching the immune system's response unfold in real time. They sequenced over 600,000 individual cells, generating a dataset so detailed it amounts to the most complete timeline of how the body responds to a new viral threat that science has yet produced. What they discovered challenged conventional thinking. The people who cleared the virus quickly did not mount the kind of broad, aggressive immune response doctors typically associate with fighting infection. Instead, they developed subtle, previously unknown innate immune responses—the body's first line of defense, working quietly and efficiently before the adaptive immune system even enters the picture.
One pattern stood out: individuals who resisted infection showed high levels of activity in a gene called HLA-DQA2 before they were ever exposed to the virus. It was as if their immune systems were already primed, already listening. Meanwhile, the six volunteers who developed sustained COVID-19 infections told a different story. Their blood mounted a rapid immune response, but their nasal tissue—the actual site of infection—responded more slowly. By the time the defenses arrived at the front lines, the virus had already established itself. The researchers also identified common patterns in how T-cell receptors activated in protected individuals, offering clues about how immune cells communicate with one another and suggesting new avenues for developing targeted therapies.
Rik Lindeboom, now at the Netherlands Cancer Institute, described the study as an "incredibly unique opportunity" to observe immune responses meeting a novel pathogen under controlled conditions where variables like timing and underlying health conditions could be accounted for. Marko Nikolic from UCL emphasized that the findings provide a much fuller picture of the entire spectrum of immune responses, potentially laying groundwork for treatments and vaccines designed to mimic the body's own protective mechanisms. Sarah Teichmann, the study's lead author and co-founder of the Human Cell Atlas, noted that as this cellular map grows more complete, researchers will be better equipped to identify which cells are truly essential for fighting infection and to understand why different people respond so differently to the same virus. The work points toward a future where medicine might be able to teach the immune system what these naturally protected people's bodies already know.
Citas Notables
An incredibly unique opportunity to see how immune responses meet a new pathogen under controlled conditions— Rik Lindeboom, Netherlands Cancer Institute
A much fuller picture of the entire spectrum of immune responses, potentially laying groundwork for treatments and vaccines designed to mimic the body's own protective mechanisms— Marko Nikolic, University College London
La Conversación del Hearth Otra perspectiva de la historia
Why does it matter that some people didn't get sick at all? Couldn't we have learned this from studying people who recovered?
The difference is timing. Once someone is sick, their immune system is already in crisis mode. By studying people who never got sick in the first place, we're seeing the immune response at its most elegant—before inflammation takes over, before the virus has a foothold. That's the moment that matters most.
So these people with the HLA-DQA2 gene activity—are they naturally immune? Is this genetic luck?
It's not quite that simple. The gene activity was present before exposure, which suggests some people's immune systems are in a state of readiness. But it's not destiny. It's more like having a smoke detector that's already switched on, versus one you have to turn on after the fire starts.
The people who got infected had a fast blood response but slow nasal response. Why does location matter so much?
Because the virus doesn't live in your bloodstream—it lives in your nose. A fast response in the wrong place is like sending firefighters to the wrong address. By the time they arrive at the actual site, the fire has already spread.
What can doctors actually do with this information?
The immediate application is vaccines and therapies that mimic what these protected people's bodies naturally do. Instead of triggering a massive inflammatory response, you could train the immune system to respond subtly and efficiently, the way these resistant individuals do.
Does this explain why some people had no symptoms while others got very sick?
It's part of the picture. This study focuses on whether infection happens at all. But yes, understanding these early protective mechanisms could eventually help us understand the full spectrum—from no infection to mild illness to severe disease.